Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunization against Marek's disease using a live attenuated virus.

× No keyword cloud information.

49 in total

1. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors: K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal: J Virol Date: 2000-04 Impact factor: 5.103

2. Effect of in vitro adaptation of Marek's disease virus on pock induction on the chorioallantoic membrane of embryonated chicken eggs.

Authors: J M Sharma; B D Coulson; E Young
Journal: Infect Immun Date: 1976-01 Impact factor: 3.441

3. Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.

Authors: K K Murthy; B W Calnek
Journal: Infect Immun Date: 1979-11 Impact factor: 3.441

Review 4. Cytomegalovirus infection in the neonate and its prevention.

Authors: H Stern
Journal: Postgrad Med J Date: 1977-10 Impact factor: 2.401

5. Vaccination against EB virus.

Authors:
Journal: Br Med J Date: 1976-12-18

6. Map location of homologous regions between Marek's disease virus and herpesvirus of turkey and the absence of detectable homology in the putative tumor-inducing gene.

Authors: K Fukuchi; M Sudo; A Tanaka; M Nonoyama
Journal: J Virol Date: 1985-03 Impact factor: 5.103

7. Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage.

Authors: R F Silva; R L Witter
Journal: J Virol Date: 1985-06 Impact factor: 5.103

Review 8. Neoplasia--what are the prospects of immunological intervention?

Authors: B T Rouse
Journal: Can Vet J Date: 1973-09 Impact factor: 1.008

9. Neoplasms, differentiations and mutations.

Authors: G B Pierce
Journal: Am J Pathol Date: 1974-10 Impact factor: 4.307

10. The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.

Authors: G R Skinner; A Buchan; C E Hartley; S P Turner; D R Williams
Journal: Med Microbiol Immunol Date: 1980 Impact factor: 3.402